• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

IJERPH, Vol. 20, Pages 6145: Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre
This study outlines reasons to initiate OAC treatment in very high-risk patients in clinical practice.
Source: International Journal of Environmental Research and Public Health - June 16, 2023 Category: Environmental Health Authors: Bernadetta Bielecka Iwona Gorczyca-G łowacka Agnieszka Ciba-Stemplewska Beata Wo żakowska-Kapłon Tags: Article Source Type: research

Pre-treatment clinical assessment in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Authors: Robson A, Sturman J, Williamson P, Conboy P, Penney S, Wood H Abstract This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. This paper provides recommendations on the pre-treatment clinical assessment of patients presenting with head and neck cancer. Recommendations • Comorbidity data should be collected as it is important in the analysis of survival, quality of life and functional outcomes after treatment as well as for comparing results of different treatment regimens and different centres. (R) • Patients with hypertens...
Source: Journal of Laryngology and Otology - November 15, 2016 Category: ENT & OMF Tags: J Laryngol Otol Source Type: research

Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.
Abstract Whether marine omega-3 fatty acid (n-3 FA) or vitamin D supplementation can prevent cardiovascular disease (CVD) in general populations at usual risk for this outcome is unknown. A major goal of VITAL (Vitamin D and Omega-3 Trial) was to fill this knowledge gap. In this article, we review the results of VITAL, discuss relevant mechanistic studies regarding n-3 FAs, vitamin D, and vascular disease, and summarize recent meta-analyses of the randomized trial evidence on these agents. VITAL was a nationwide, randomized, placebo-controlled, 2×2 factorial trial of marine n-3 FAs (1 g/d) and vitamin D3 (2000 IU...
Source: Circulation Research - January 2, 2020 Category: Cardiology Authors: Manson JE, Bassuk SS, Cook NR, Lee IM, Mora S, Albert CM, Buring JE, VITAL Research Group Tags: Circ Res Source Type: research

Impact of previous percutaneous coronary intervention on cardiovascular outcomes and mortality after lung cancer surgery: A nationwide study in Korea
ConclusionsPatients who underwent PCI before surgery for lung cancer were at a higher risk of death than those in the non ‐PCI group at one year after surgery. In addition, they showed higher short‐ and long‐term risks of revascularization than patients in the non‐PCI group. Careful long‐term management of cardiovascular risk is necessary for this population.
Source: Thoracic Cancer - July 11, 2020 Category: Cancer & Oncology Authors: Dong Woog Yoon, Dong Wook Shin, Jong Ho Cho, Jong ‐Hwan Lee, Jeong Hoon Yang, Kyungdo Han, Sang Hyun Park Tags: ORIGINAL ARTICLE Source Type: research

The Effect of a Cancer History on Patients with Acute Myocardial Infarction After Percutaneous Coronary Intervention
Int Heart J. 2021 Mar 17. doi: 10.1536/ihj.20-452. Online ahead of print.ABSTRACTThe effect of a history of cancer on the prognosis of patients with acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI) is poorly understood.From the Osaka Acute Coronary Insufficiency Study (OACIS) registry in Osaka, Japan, we enrolled the case data of a total of 3499 patients with AMI treated with PCI between 1998 and 2014, of whom 462 had a cancer history (cancer group, 13.2%) and 3037 did not (non-cancer group, 86.8%). All of the cases were followed for up to five years from discharge.The Kaplan-Meier curve and...
Source: International Heart Journal - March 18, 2021 Category: Cardiology Authors: Taro Takeuchi Shungo Hikoso Satoshi Hattori Tetsuhisa Kitamura Daisaku Nakatani Hiroya Mizuno Katsuki Okada Tomoharu Dohi Takayuki Kojima Hirota Kida Akihiro Sunaga Bolrathanak Oeun Taiki Sato Yasuhiko Sakata Hiroshi Sato Masatsugu Hori Issei Komuro Tomot Source Type: research

Effects of Smoking on Long-Term Clinical Outcomes and Lung Cancer in Patients with Acute Myocardial Infarction
CONCLUSIONS: In contrast to the unadjusted model, smoking is associated with worse cardiovascular outcome and higher incidence of lung cancer after adjustment of various confounding factors. This result can be explained by the characteristics of smokers, which were young and had fewer comorbidities.PMID:33821583 | DOI:10.4070/kcj.2020.0430
Source: Korean Circulation Journal - April 6, 2021 Category: Cardiology Authors: Su Nam Lee Ik Jun Choi Sungmin Lim Eun Ho Choo Byung Hee Hwang Chan Joon Kim Mahn Won Park Jong Min Lee Chul Soo Park Hee Yeol Kim Ki Dong Yoo Doo Soo Jeon Ho Joong Youn Wook Sung Chung Min Chul Kim Myung Ho Jeong Youngkeun Ahn Kiyuk Chang Source Type: research

Pages: 1  2  3  4